The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis

Abstract Background Nafamostat mesilate decreases the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). However, no studies have administered nafamostat mesilate after ERCP. So we investigated if the infusion of nafamostat mesilate after ERCP can affect the post-...

Cijeli opis

Bibliografski detalji

Glavni autori:	Joo Seong Kim, Sang Hyub Lee, Namyoung Park, Gunn Huh, Jung Won Chun, Jin Ho Choi, In Rae Cho, Woo Hyun Paik, Ji Kon Ryu, Yong-Tae Kim
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2022-05-01
Serija:	BMC Gastroenterology
Teme:	Nafamostat Endoscopic retrograde cholangiopancreatography Post-ERCP pancreatitis
Online pristup:	https://doi.org/10.1186/s12876-022-02345-3
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!